Tesoro Corporation (TSO) Moves Higher on Volume Spike for June 09

Equities Staff |

Tesoro Corporation (TSO) traded on unusually high volume on Jun. 09, as the stock gained 2.59% to close at $91.78. On the day, Tesoro Corporation saw 4.26 million shares trade hands on 33,802 trades. Considering that the stock averages only a daily volume of 2.46 million shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $93.06 and $69.49 over the last 52-weeks, its 50-day SMA is now $81.23, and its 200-day SMA $81.86. Tesoro Corporation has a P/B ratio of 2.68. It also has a P/E ratio of 15.

Tesoro Corp is an independent petroleum refiner and marketer in the United States. Its subsidiaries operate through three business segments, transport crude oil and manufacture, transport and sell transportation fuels.

Headquartered in San Antonio, TX, Tesoro Corporation has 6,300 employees and is currently under the leadership of CEO Gregory J. Goff.

For a complete fundamental analysis analysis of Tesoro Corporation, check out Equities.com’s Stock Valuation Analysis report for TSO.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

To get more information on Tesoro Corporation and to follow the company’s latest updates, you can visit the company’s profile page here: TSO’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…